Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion

Catheterization and Cardiovascular Interventions

Volumn 67, Issue 3, 2006, Pages 344-348

  Migliorini, Angela ^a   Moschi, Guia ^a   Vergara, Ruben ^a   Parodi, Guido ^a   Carrabba, Nazario ^a   Antoniucci, David ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Drug eluting stents; Percutaneous coronary intervention; Total occlusions

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; BARE METAL STENT; CHRONIC TOTAL OCCLUSION; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG ELUTING STENT; HEART DISEASE; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS; RISK REDUCTION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PACLITAXEL; PROPORTIONAL HAZARDS MODELS; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 33644767984     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.20623     Document Type: Article

References (14)

1. Morice M-C, Serruys PW, Sousa E, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780.
2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
3. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
4. Hoye A, Tanabe K, Lemos PA, Aoki J, Saia F, Arampatzis C, Degertekin M, Hofma SH, Sianos G, McFadden E, et al. Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions. J Am Coll Cardiol 2004;43:1954-1958.
5. Werner GS, Krack A, Schwarz G, Prochnau D, Betge S, Figulla HR. Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents. J Am Coll Cardiol 2004;44:2301-2306.
6. Ge L, Iakovou I, Cosgrave J, Chieffo A, Montorfano M, Michev I, Airoldi F, Carlino M, Melzi G, Sangiorgi GM, et al. Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlussions. Eur Heart J 2005;11:1056-1062.
7. Nakamura S, Matheusamy TS, Bee J-H, Cahyadi YS, Udayachalerm W, Tresukosol D. Impact of sirolimus-eluting stent on the outcome of patients with chronic total occlusion. Am J Cardiol 2005;55:161-166.
8. Lemos PA, Hoye A, Goedhart D, Arampatzis CA, Saia F, van der Giessen WJ, McFadden E, Sianos G, Smits PC, Hofma SH, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the rapamycin-eluting stent evaluated at Rotterdam cardiology hospital (RESEARCH) study. Circulation 2004;109:1366-1370.
9. Lemos PA, Serruys PW, van Domburg RT, Saia F, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Daemen J, Liu TK, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the rapamycin-eluting stent evaluated at Rotterdam cardiology hospital (RESEARCH) registry. Circulation 2004;109: 140-142.
10. Kastrati A, Schomig A, Elezi S, Schuhlen H, Dirschinger J, Hadamitzky M, Wehinger A, Hausleiter J, Walter H, Neumann FJ. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 1997;30:1428-1436.
11. Bauters C, Hubert E, Prat A, Bougrimi K, Van Belle E, McFadden EP, Amouyel P, Lablanche JM, Bertrand M. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol 1998;31:1291-1298.
12. Antoniucci D, Valenti R, Santoro GM, Bolognese L, Trapani M, Cerisano G, Boddi V, Fazzini PF. Restenosis after coronary stenting in current clinical practice. Am Heart J 1998;135:510-518.
13. Serruys PW, Kay IP, Disco C, Deshpande NV, de Feyter PJ. Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the Belgian Netherlands stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and MUSIC trials. Multicenter ultrasound stent in coronaries. J Am Coll Cardiol 1999;34:1067-1074.
14. Hausleiter J, Kastrati A, Mehilli J, Schuhlen H, Pache J, Dotzer F, Dirschinger J, Schomig A. Predictive factors for early cardiac events and angiographic restenosis after coronary stent placement in small coronary arteries. J Am Coll Cardiol 2002;40: 882-889.